7.3.2.7	  Summary of evidence and recommendations for local therapy of metastases in metastatic RCC,
Summary of evidence,LE
"Retrospective comparative studies consistently point towards a benefit of complete metastasectomy   in mRCC patients in terms of OS, CSS and delay of systemic therapy.",3
A single-arm prospective and retrospective study support that oligometastases can be observed for   up to 16 months before systemic therapy is required due to progression.,2a
"Radiotherapy to bone and brain metastases from RCC can induce significant relief from local   symptoms (e.g., pain).",3
Tyrosine kinase inhibitors treatment after metastasectomy in patients with no evidence of disease did   not improve RFS when compared to placebo or observation.,1b
